Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

MLH1 and XRCC1 polymorphisms in Mexican patients with colorectal cancer.

Muñiz-Mendoza R, Ayala-Madrigal ML, Partida-Pérez M, Peregrina-Sandoval J, Leal-Ugarte E, Macías-Gómez N, Peralta-Leal V, Meza-Espinoza JP, Moreno-Ortiz JM, Ramírez-Ramírez R, Suárez-Villanueva S, Gutiérrez-Angulo M.

Genet Mol Res. 2012 Aug 13;11(3):2315-20. doi: 10.4238/2012.June.27.6.

PMID:
22843073
2.

A MLH1 polymorphism that increases cancer risk is associated with better outcome in sporadic colorectal cancer.

Nejda N, Iglesias D, Moreno Azcoita M, Medina Arana V, González-Aguilera JJ, Fernández-Peralta AM.

Cancer Genet Cytogenet. 2009 Sep;193(2):71-7. doi: 10.1016/j.cancergencyto.2009.04.011.

PMID:
19665066
3.

MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.

Raptis S, Mrkonjic M, Green RC, Pethe VV, Monga N, Chan YM, Daftary D, Dicks E, Younghusband BH, Parfrey PS, Gallinger SS, McLaughlin JR, Knight JA, Bapat B.

J Natl Cancer Inst. 2007 Mar 21;99(6):463-74.

PMID:
17374836
4.

Association between MLH1 -93G>a polymorphism and risk of colorectal cancer.

Wang T, Liu Y, Sima L, Shi L, Wang Z, Ni C, Zhang Z, Wang M.

PLoS One. 2012;7(11):e50449. doi: 10.1371/journal.pone.0050449. Epub 2012 Nov 30.

5.

Contribution of the MLH1 -93G>a promoter polymorphism in modulating susceptibility risk in Malaysian colorectal cancer patients.

Nizam ZM, Abdul Aziz AA, Kaur G, Abu Hassan MR, Mohd Sidek AS, Yeh LY, Mazuwin M, Ankathil R.

Asian Pac J Cancer Prev. 2013;14(2):619-24.

6.

[Association of MLH1 gene 415G/C polymorphism with colorectal cancer in Chinese].

Tao WP, Hu S, Feng JP, Xie YS.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Jun;26(3):314-7. doi: 10.3760/cma.j.issn.1003-9406.2009.03.017. Chinese.

PMID:
19504447
7.

MLH1 -93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer.

Allan JM, Shorto J, Adlard J, Bury J, Coggins R, George R, Katory M, Quirke P, Richman S, Scott D, Scott K, Seymour M, Travis LB, Worrillow LJ, Bishop DT, Cox A; UK NCRI Colorectal Clinical Studies Group; Colorectal Cancer Study Group.

Int J Cancer. 2008 Nov 15;123(10):2456-9. doi: 10.1002/ijc.23770.

8.

Haplotype defined by the MLH1-93G/A polymorphism is associated with MLH1 promoter hypermethylation in sporadic colorectal cancers.

Miyakura Y, Tahara M, Lefor AT, Yasuda Y, Sugano K.

BMC Res Notes. 2014 Nov 24;7:835. doi: 10.1186/1756-0500-7-835.

9.

Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients.

Mangoni M, Bisanzi S, Carozzi F, Sani C, Biti G, Livi L, Barletta E, Costantini AS, Gorini G.

Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):52-8. doi: 10.1016/j.ijrobp.2010.04.023. Epub 2010 Aug 12.

PMID:
20708344
10.

Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers.

Lo YL, Hsiao CF, Jou YS, Chang GC, Tsai YH, Su WC, Chen KY, Chen YM, Huang MS, Hsieh WS, Chen CJ, Hsiung CA.

Lung Cancer. 2011 Jun;72(3):280-6. doi: 10.1016/j.lungcan.2010.10.009. Epub 2010 Nov 19.

PMID:
21093954
11.

DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome.

Reeves SG, Meldrum C, Groombridge C, Spigelman A, Suchy J, Kurzawski G, Lubinski J, Scott RJ.

Cancer Epidemiol. 2012 Apr;36(2):183-9. doi: 10.1016/j.canep.2011.09.003. Epub 2011 Oct 5.

PMID:
21974800
12.

MLH1-93G > A is a risk factor for MSI colorectal cancer.

Whiffin N, Broderick P, Lubbe SJ, Pittman AM, Penegar S, Chandler I, Houlston RS.

Carcinogenesis. 2011 Aug;32(8):1157-61. doi: 10.1093/carcin/bgr089. Epub 2011 May 11.

PMID:
21565826
13.

Molecular analysis of imperative polymorphisms of MLH1 gene in sporadic colorectal cancer.

Milanizadeh S, Khanyaghma M, Haghighi MM, Mohebbi S, Damavand B, Almasi S, Azimzadeh P, Zali M.

Cancer Biomark. 2013 Jan 1;13(6):427-32. doi: 10.3233/CBM-140391.

PMID:
24595079
14.

Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors.

Campbell PT, Curtin K, Ulrich CM, Samowitz WS, Bigler J, Velicer CM, Caan B, Potter JD, Slattery ML.

Gut. 2009 May;58(5):661-7. doi: 10.1136/gut.2007.144220. Epub 2008 Jun 3.

15.

RUNX3 gene polymorphisms and haplotypes in Mexican patients with colorectal cancer.

Suárez-Villanueva S, Ayala-Madrigal ML, Peregrina-Sandoval J, Macías-Gómez N, Ramírez-Ramírez R, Muñiz-Mendoza R, Moreno-Ortiz JM, Centeno-Flores M, Maciel-Gutiérrez V, Cabrales E, Gutiérrez-Angulo M.

Genet Mol Res. 2015 Dec 1;14(4):15505-10. doi: 10.4238/2015.November.30.28.

16.

Effect of MLH1 -93G>A on gene expression in patients with colorectal cancer.

Funck A, Santos JC, Silva-Fernandes IJ, Rabenhorst SH, Martinez CA, Ribeiro ML.

Med Oncol. 2014 Sep;31(9):160. doi: 10.1007/s12032-014-0160-z. Epub 2014 Aug 13.

PMID:
25115745
17.

Association of DCC, MLH1, GSTT1, GSTM1, and TP53 gene polymorphisms with colorectal cancer in Kazakhstan.

Djansugurova L, Zhunussova G, Khussainova E, Iksan O, Afonin G, Kaidarova D, Parker MI.

Tumour Biol. 2015 Jan;36(1):279-89. doi: 10.1007/s13277-014-2641-2. Epub 2014 Sep 24.

PMID:
25249451
18.

Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.

Improta G, Sgambato A, Bianchino G, Zupa A, Grieco V, La Torre G, Traficante A, Cittadini A.

Anticancer Res. 2008 Sep-Oct;28(5B):2941-6.

19.

Genetic polymorphisms in XRCC1 genes and colorectal cancer susceptibility.

Huang Y, Li X, He J, Chen L, Huang H, Liang M, Zhu Q, Huang Y, Wang L, Pan C, Xia T.

World J Surg Oncol. 2015 Aug 15;13:244. doi: 10.1186/s12957-015-0650-2.

20.

Interaction between polymorphisms of DNA repair genes significantly modulated bladder cancer risk.

Zhi Y, Yu J, Liu Y, Wei Q, Yuan F, Zhou X, Song B, Chen Z, Yang J.

Int J Med Sci. 2012;9(6):498-505. doi: 10.7150/ijms.4799. Epub 2012 Aug 17.

Supplemental Content

Support Center